Clinical Research Directory

Inclusion Criteria : To be considered eligible to participate in this study, a patient must meet the inclusion criteria listed below: 1. Patients that have completed the KS-GIG-001-01 Study and were in the Active Treatment group 2. Patients having signed the consent forms for both the KS-GIG-001-01 Study and this Long Term, 3-Year Follow-up Study Exclusion Criteria : To be eligible for entry into the study, the patient must not meet any of the exclusion criteria listed below: 1\. Enrollment in another AAV or other gene therapy trial